Theriva Biologics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Theriva Biologics, Inc. (TOVX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $693.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-11
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $693.00K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $835.00K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $694.00K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $847.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $693.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $835.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $694.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $847.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.30M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $495.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $596.00K 10-K · filed 2025-03-06 |
| 2024-09-30 | $758.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $934.00B 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.30M 10-K · filed 2024-03-25 |
| 2023-09-30 | $539.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $673.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $841.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $997.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $395.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $516.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $624.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $771.00K 10-K · filed 2022-03-16 |
| 2021-09-30 | $380.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $483.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $585.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $686.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | $406.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $498.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $577.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $681.00K 10-K · filed 2020-02-20 |
| 2019-09-30 | $305.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $422.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $540.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $824.00K 10-K · filed 2019-02-27 |
| 2018-09-30 | $1.07M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.60M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.10M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.90M 10-K · filed 2018-02-22 |
| 2017-09-30 | $3.70M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $4.60M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $5.60M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $6.40M 10-K · filed 2017-03-02 |
| 2016-09-30 | $5.70M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $6.80M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $7.30M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $8.30M 10-K · filed 2016-03-10 |
| 2015-09-30 | $4.60M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $5.30M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $4.70M 10-K · filed 2015-03-16 |
| 2013-12-31 | $1.60M 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.90M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.20M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.90M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.20M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |